Payment et al. 1991 |
Canada |
River receiving sewage; coliforms and viruses detected |
Conventional treatment with ozonation and chlorination; effluent in compliance with regulations; no coliforms or viruses in effluent |
Negative pressures; inadequate residual |
CRT, nonblinded |
RO-treated water |
IDR = 1.36 (1.10, 1.69)a
|
Payment et al. 1997 |
Canada |
Same river as for Payment et al. 1991; coliforms, parasites, and viruses detected |
Conventional treatment with ozonation and chlorination; effluent in compliance with regulations; no coliforms, parasites, or viruses in effluent |
Same system as for Payment et al. 1991; no fecal coliforms; coliforms detected in 0.6% of samples |
CRT, nonblinded |
Ozonated bottles of RO-treated plant water or spring water |
IDR = 1.14 (0.91, 1.42)a
|
Semenza et al. 1998 |
Uzbekistan |
Not reported |
Two-stage chlorination |
Pressure-loss events; inadequate residual |
Cohort,b nonblinded |
Chlorinated water |
IDR = 2.61 (1.71, 4.00)a
|
Hellard et al. 2001 |
Australia |
Protected forest catchments; fecal coliforms detected |
Chlorination; no coliforms in effluent |
Inadequate residual; no fecal coliforms; coliforms detected in 19% of samples |
CRT, blinded |
Microfiltration + UV |
IDR = 1.00 (0.86, 1.15) |
Colford et al. 2002 |
USA |
River receiving agriculture and industry runoff; pathogens detected |
Conventional treatment with chloramination; effluent in compliance with regulations |
Not reported |
CRT, blinded |
Microfiltration + UV |
IDR = 1.32 (0.75, 2.33) |
Colford et al. 2005b |
USA |
River receiving sewage; parasites and viruses detected |
Conventional treatment with chlorination; effluent in compliance with regulations; no coliforms, parasites, or viruses in effluent |
No negative pressures; adequate residual; no coliforms |
CRT, blinded |
Microfiltration + UV |
IDR = 0.96 (0.85, 1.08) |
Abbreviations: CRT, cluster-randomized trial; IDR, incidence density ratio; POU, point of use; RO, reverse osmosis; UV, ultraviolet. aCalculated from data reported in study. bObservational arm within cluster-randomized trial. |